| Dr Vanessa Givens, MD | |
|
7800 Wolf Trail Cv, Germantown, TN 38138-1753 | |
| (901) 682-9222 | |
| (901) 682-9505 |
| Full Name | Dr Vanessa Givens |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 7800 Wolf Trail Cv, Germantown, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205892437 | NPI | - | NPPES |
| 3863530 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35115 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Poplar Bluff Regional Medical Center | Poplar bluff, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Big Springs Medical Association | 6709871007 | 36 |
News Archive
Dialysis patients who smoke are much less likely to receive a life-saving kidney transplant and much more likely to die sooner according to researchers from the Health Research Institute (HRI) at the University of Limerick and UL's Graduate Entry Medical School.
The American Chemistry Council (ACC) offers the following comments in response to queries regarding a study by Joe M. Braun, MSPH, Ph.D., et al. published on-line today in Pediatrics and titled "Impact of Early-Life Bisphenol A Exposure on Behavior and Executive Function in Children."
Vaccination rate figures show that older Australians are well protected against the flu but less so against pneumococcal disease and whooping cough. These figures were revealed by the Australian Institute of Health and Welfare (AIHW) and they show three-quarters of Australians aged 65 years and older had a flu shot in 2009. Just over half (55 per cent) were also vaccinated against pneumococcal disease.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.
› Verified 5 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245277631 PECOS PAC ID: 7416865845 Enrollment ID: O20031104000060 |
News Archive
Dialysis patients who smoke are much less likely to receive a life-saving kidney transplant and much more likely to die sooner according to researchers from the Health Research Institute (HRI) at the University of Limerick and UL's Graduate Entry Medical School.
The American Chemistry Council (ACC) offers the following comments in response to queries regarding a study by Joe M. Braun, MSPH, Ph.D., et al. published on-line today in Pediatrics and titled "Impact of Early-Life Bisphenol A Exposure on Behavior and Executive Function in Children."
Vaccination rate figures show that older Australians are well protected against the flu but less so against pneumococcal disease and whooping cough. These figures were revealed by the Australian Institute of Health and Welfare (AIHW) and they show three-quarters of Australians aged 65 years and older had a flu shot in 2009. Just over half (55 per cent) were also vaccinated against pneumococcal disease.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.
› Verified 5 days ago
| Entity Name | Big Springs Medical Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225045321 PECOS PAC ID: 6709871007 Enrollment ID: O20040416000695 |
News Archive
Dialysis patients who smoke are much less likely to receive a life-saving kidney transplant and much more likely to die sooner according to researchers from the Health Research Institute (HRI) at the University of Limerick and UL's Graduate Entry Medical School.
The American Chemistry Council (ACC) offers the following comments in response to queries regarding a study by Joe M. Braun, MSPH, Ph.D., et al. published on-line today in Pediatrics and titled "Impact of Early-Life Bisphenol A Exposure on Behavior and Executive Function in Children."
Vaccination rate figures show that older Australians are well protected against the flu but less so against pneumococcal disease and whooping cough. These figures were revealed by the Australian Institute of Health and Welfare (AIHW) and they show three-quarters of Australians aged 65 years and older had a flu shot in 2009. Just over half (55 per cent) were also vaccinated against pneumococcal disease.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vanessa Givens, MD 3249 W Sarazens Cir, Memphis, TN 38125-0807 Ph: (901) 756-5565 | Dr Vanessa Givens, MD 7800 Wolf Trail Cv, Germantown, TN 38138-1753 Ph: (901) 682-9222 |
News Archive
Dialysis patients who smoke are much less likely to receive a life-saving kidney transplant and much more likely to die sooner according to researchers from the Health Research Institute (HRI) at the University of Limerick and UL's Graduate Entry Medical School.
The American Chemistry Council (ACC) offers the following comments in response to queries regarding a study by Joe M. Braun, MSPH, Ph.D., et al. published on-line today in Pediatrics and titled "Impact of Early-Life Bisphenol A Exposure on Behavior and Executive Function in Children."
Vaccination rate figures show that older Australians are well protected against the flu but less so against pneumococcal disease and whooping cough. These figures were revealed by the Australian Institute of Health and Welfare (AIHW) and they show three-quarters of Australians aged 65 years and older had a flu shot in 2009. Just over half (55 per cent) were also vaccinated against pneumococcal disease.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma.
Baxano, Inc. today announced the closing of a $30 million Series C round of venture funding, led by new investor CMEA Capital. Funds were also contributed by new investors Kaiser Permanente Ventures and Affinity Capital Management and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners.
› Verified 5 days ago
Heather O Donato, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7205 Wolf River Blvd, Suite 150, Germantown, TN 38138 Phone: 901-752-4500 Fax: 901-752-4328 | |
Ms. Melvinie Seymore, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7705 Poplar Ave., Bldg B Ste 110, Germantown, TN 38138 Phone: 901-755-8696 Fax: 901-755-7232 | |
Mary N Mcdonald, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7205 Wolf River Blvd, Suite 150, Germantown, TN 38138 Phone: 901-752-4500 Fax: 901-752-4328 | |
Dr. Michael Ulm, M.D, M.S. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7945 Wolf River Blvd, Germantown, TN 38138 Phone: 901-683-0055 | |
Dr. Adam Christopher Elnaggar, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7945 Wolf River Blvd, Germantown, TN 38138 Phone: 901-683-0055 Fax: 901-685-2969 | |
Amy Ling-an Kung Nelson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7800 Wolf Trail Cv, Germantown, TN 38138 Phone: 901-682-9222 Fax: 901-682-9505 |